Clinical Centre of Serbia   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Belgrade Serbia (1983)

Organization Overview

First Clinical Trial
2009
NCT01211925
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Clinical Center of Serbia in Belgrade, Clinic for Vascular and Endovascular Surgery | Clinical Centre of Sebria | Clinical Centre of Serbia

Active Ingredients

Drugs in Phase 4 Trials (1)

saccharomyces boulardii (2 trials)

Drugs in Phase 3 Trials (2)

acetylsalicylic acid (aspirin) (2 trials)

ticagrelor (brilinta) (1 trial)

Drugs in Other Trials (3)

epinephrine (levophed) (1 trial)

heparin (liquaemin) (1 trial)

lidocaine (xylocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Helicobacter Infections (Phase 4)

Infarction (Phase 3)

Infections (Phase 4)

Ischemia (Phase 3)

Myocardial Infarction (Phase 3)

ST Elevation Myocardial Infarction (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 6